Slc26a4 regulatory elements and uses thereof
AssigneeDecibel Therapeutics, Inc.
InventorsTyler GIBSON, Monika KOWALCZYK, Gabriela PREGERNIG, Jonathan B. SELLON, Kathy SO
Life of this patent
Estimating the term…
Loading patent…
AssigneeDecibel Therapeutics, Inc.
InventorsTyler GIBSON, Monika KOWALCZYK, Gabriela PREGERNIG, Jonathan B. SELLON, Kathy SO
Estimating the term…
The disclosure provides SL26A4 enhancers and SLC26A4 promoters, as well as vectors containing the same, that can increase gene expression in SLC26A4-expressing cells, such as interdental cells, root cells, spiral prominence cells, and vestibular supporting cells. The SLC26A4 enhancers and SLC26A4 promoters described herein may be operably linked to a polynucleotide, such as a transgene, encoding an expression product and used for the treatment of subjects having or at risk of developing hearing loss or vestibular dysfunction.
A polynucleotide comprising an enhancer having at least 85% sequence identity to a nucleotide sequence of SEQ ID NO:
Dependencies are inferred from the claim text.